Venn Life Sciences and Encorium to merge

Wednesday, February 22, 2012 01:57 PM

Finland-based CRO Encorium Group and Venn Life Sciences, a provider of development consulting and resourcing services based in Dublin, Ireland, have agreed to merge.

The combined operation will be named Venn Life Sciences Limited, will be headquartered in Ireland and will have over 200 employees operating from over 20 locations worldwide.

The management team and board of the combined entity will be comprised of existing management of both companies. Leading the management team will be Sean Leech, Venn’s current CEO. The board will be led by Dr. Kai Lindevall, Encoriums’ current CEO.

“Our combined management, operational and project teams have many years of clinical and consulting experience in the various forms of clinical development models. This variation of experience will be a critical component to future success in the clinical outsourcing arena,” said Tony Richardson, executive chairman of Venn.

“I am pleased that the months of planning have yielded a successful outcome and one that will ensure continuity of business for our clients and employees,” said Dr. Lindevall.

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs